Journal article icon

Journal article

Endothelial Slit2 guides the Robo1-positive sympathetic innervation during heart development

Abstract:
Axon guidance cues direct nerves in the heart during development, disease, and regeneration. These cues determine cardiac innervation patterning by regulating the balance between chemo-attraction and chemo-repulsion. However, the role of one of the most crucial ligand-receptor combinations among axon guidance molecules, the Slit chemo-active ligands and their Roundabout (Robo) transmembrane receptors, remains unknown during cardiac innervation patterning. To test if Slit-Robo signalling is important for cardiac innervation guidance, we analysed Slit and Robo mouse knock-outs. Constitutive Slit2-/- ventricles showed significantly reduced innervation, while Slit3-/- hearts showed temporary increased levels of innervation compared to wild-type littermate controls. Whereas innervation was not affected in Robo2-/-mice, the phenotype seen in Slit2-/- ventricles was recapitulated in Robo1-/- mice. Detailed expression analysis identified expression of Slit2 ligand in the endothelium of the coronary vessels, while Slit3 was highly present in the coronary smooth muscle wall and in the innervation. Both the Robo1 and Robo2 receptors were present in the nerves and at low levels in the vessels. Knocking out Slit2 specifically in the endothelium recapitulated the defects seen in the constitutive Slit2-/- hearts. Ex vivo axon guidance cultures showed that attraction of axons extending from the ganglia was strongly reduced in ventricles with absence of endothelial Slit2 compared to wild-type controls. In the absence of endothelial Slit2, adult mice showed reduced response to challenging the sympathetic innervation. In conclusion, we have identified an important new chemo-active Slit2-Robo1 pathway required for correct cardiac innervation development.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Authors

More by this author
Institution:
University of Oxford
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Paediatrics
Sub department:
IDRM (Paediatrics)
Role:
Author
ORCID:
0000-0002-5814-7166
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Paediatrics
Sub department:
IDRM (Paediatrics)
Role:
Author
ORCID:
0000-0001-5044-2876
More by this author
Institution:
University of Oxford
Role:
Author
More by this author
Role:
Author
ORCID:
0000-0003-2023-6304



Publisher:
eLife Sciences Publications
Journal:
eLife More from this journal
Volume:
14
Article number:
RP105932
Publication date:
2025-12-17
DOI:
EISSN:
2050-084X
ISSN:
2050-084X


Language:
English
Keywords:
Pubs id:
2123699
UUID:
uuid_98f9de2b-5e51-45e3-bb4c-d17343d593a0
Local pid:
pubs:2123699
Source identifiers:
3574665
Deposit date:
2025-12-18
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP